B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies. (2020)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2020.622442
PubMed Identifier: 33569063
Publication URI: http://europepmc.org/abstract/MED/33569063
Type: Journal Article/Review
Volume: 11
Parent Publication: Frontiers in immunology
ISSN: 1664-3224